Biodegradable-polymer versus durable-polymer drug-eluting stents in left main percutaneous coronary intervention: final results of the randomised IDEAL-LM trial
Alexander M Griffioen(Radboud University Nijmegen), Keith G. Oldroyd(Biosensores (Spain)), Robert‐Jan van Geuns(Erasmus MC), Aleksey Protopopov(Krasnoyarsk Regional Clinical Hospital), Adrian Włodarczak(Centrum Badań Jakości), Colm G. Hanratty(Belfast Health and Social Care Trust), Paul Barragan(Hôpital Privé Marseille Beauregard), Erwan Bressollette(Nouvelles Cliniques Nantaises), Е. В. Меркулов(Institute of Experimental Cardiology), Oleg Krestyaninov(Novosibirsk State Medical University), Peter O’Kane(Royal Bournemouth Hospital), Еvgeny Kretov(Meshalkin National Medical Research Center), Maciej Lesiak, Aaron Peace(Western Health and Social Care Trust), Ian Menown(Craigavon Area Hospital), Marc Silvestri, Richard Anderson(University Hospital of Wales), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Paul Rocchiccioli(Golden Jubilee National Hospital), Margaret McEntegart(Golden Jubilee National Hospital)
Cited by 0
Related Papers
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Randomized Trial of Preventive Angioplasty in Myocardial Infarction
|New England Journal of Medicine|2013|1k